Head and Neck Unit, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.
Eur Arch Otorhinolaryngol. 2010 Dec;267(12):1969-71. doi: 10.1007/s00405-010-1377-x. Epub 2010 Sep 11.
Optimal care of patients with head and neck squamous cell cancer (HNSCC) involves a pre-determined period of post-treatment follow-up for the detection of recurrent or persistent disease, metastases and second primaries at the earliest opportunity. There is little evidence in literature as to whether the surveillance schemes should be based on patient survival, quality of life or cost-adjusted parameters. This article aims at highlighting some of the issues pertinent to the optimization of surveillance strategies in HNSCC.
头颈部鳞状细胞癌（HNSCC）患者的最佳治疗需要在治疗后确定一个预先设定的随访期，以便尽早发现复发或持续性疾病、转移和第二原发癌。关于监测方案应该基于患者生存、生活质量还是成本调整参数，文献中几乎没有证据。本文旨在强调与 HNSCC 监测策略优化相关的一些问题。
